NG

Neeraj G.

Father | Entrepreneur | CRE Operator | Angel Investor | Business Philomath

Greater Philadelphia

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Principal

    2017

    Gupta Property Management LLC, dba Gupta Communities manages a portfolio of 122 units owned in Chester County, PA. Our specialty is driving NOI through prudent financial management of the entire p&l using data analytics and technology to drive customer acquisitions, automate and simplify day to day operations.

  • Managing Partner

    2017

    Gupta Capital Holdings, LLC is an asset management firm specializing in long-term commercial real estate investments within the Philadelphia 5 counties. The company also invests in mid-Atlantic based startups through it’s angel fund as well as in traditional publicly traded assets.

  • Member

    2018

    Broad Street Angels is an angel investor group formed by like-minded individual investors and is affiliated with the Union League in Philadelphia, PA. The group's mandate is to support early stage businesses seeking pre-IPO funding and based in the Mid-Atlantic region. Most industries are welcome to present for funding with the exception of real estate. If you are interested in learning more or if you think we could help you grow your business, please let me know.

  • Office Associate

    2015 - 2017

    RAM Properties, LLC owns and manages a 64 unit garden style apartment complex.

2015 - 2015

  • Finance Director, Global Oncology

    2015 - 2015

    Finance integration lead for Oncology portfolio of assets acquired from GSK Pharmaceuticals. + Represent Novartis on joint steering committee with GSK + Work across Novartis subsidiaries to help address ad-hoc business issues stemming from integration + Track Transitional Service Agreement to ensure appropriate coverage and billings as necessary + Prepare month end reporting package for Pharma CFO showing acquired business carve-out performance versus Budget/Latest Outlook and Operating/Extrodinary cost split + Forecast total integration costs and provide ad-hoc analysis including currency impact due to phased transition of distribution from GSK

2013 - 2015

  • Finance Director, Global Oncology Franchise

    2013 - 2015

    Finance Partner for Global Oncology Franchise at GSK supporting a broad range of Teams and Assets including TAFINLAR, MEKINIST, ARZERRA, R&D Commercial Insights, Field Market Leads and Operations. + Partner with market access to set global pricing strategy for new product or indication launches. Work with regional and country specific teams to implement strategy with focus of maximizing patient access and profitability. + Work across markets to ensure standardized forecast assumptions, monitor and flag forecast updates by country to Medicine Commercialization Team. Challenge forecasts where appropriate. + Partner with Commercial Analytics to refresh 10 year global forecasts to help inform long-term strategy. + Work with clinical project managers to quantify financial values for potential phase IIIB/IV studies. + Understand underlying business drivers for top 8 key markets and inform Leadership to help drive performance. + Established a month end accounting process to capture accruals across brands and cost centers for the newly create Global Oncology Franchise. + Ad hoc projects as necessary to support the Franchise. Special Project: + Supported Launch of the Name Patient Program for TAFINLAR & MEKINIST through driving the creation of financial, forecasting, and supply chain processes.

  • Councilman, Ward 1

    2012 - 2014

    Elected Member of Conshohocken Borough Council. Chair of Finance, Transportation and Economic Development Committee. Member of the Parks & Grounds and Personnel Committees. + Held taxes flat three consecutive years through challenging spends and reducing non-core expenses. + Created a public/private partnership with a local business to develop riverfront amenities, resulting in a Borough owned dog park and helipad without investing public funds. + Led efforts to update zoning along riverfront to reduce density in order to create more sustainable long-term development. + Worked with lead labor negotiator on new Public Works union contract, introduced first in region concept of co-sharing healthcare costs.

2003 - 2013

  • Sr. Finance Manager, Managed Markets

    2011 - 2013

    Responsible for the financial evaluation of all potential managed market contracts for a portfolio of brands including Nexium, Toprol-XL and Pulmicort Respules. Forecast demand utilization by payer segment and lead the monthly accounting close for a portfolio of products with an open balance liability exceeding $1B. + Evaluate market access opportunities and partner with negotiators to bring deals to a successful conclusion. + Partner with Senior Finance Lead to deliver financial targets, while maintaining an objective viewpoint to minimize risk to the business. + Supported numerous supply chain and market access pilot programs through development of business cases. + Lead a staff of senior financial analysts Special Project: + Worked on cross functional team to conceptualize and implement a comprehensive post patent strategy for NEXIUM to maximize tail through single source generic competition.

  • Finance Brand Manager, Seroquel Franchise

    2010 - 2011

    The Finance Brand Manager leads and manages all financial aspects of the monthly close, budgets, forecasts and management reporting responsibilities for the Seroquel Franchise, a $5B in sales per annum CNS brand. Responsibilities include: + Preparation of the annual, quarterly and long range budgeting process + Analyze sales and marketing expense variances and provide monthly commentary on key drivers + Complete the monthly accounting close process + Provide financial support and analysis to business partners Special Project: + Lead the Finance Internship program by recruiting, hiring and managing administrative responsibilities supporting nine interns during the summer months within multiple functions of Finance.

  • Sr. Financial Analyst

    2007 - 2009

    Support Senior Leaders in managing the Oncology and Hospital portfolio totaling $2.2B in annual sales. The product portfolio consisted of Arimidex, Casodex, Faslodex, Zoladex, Ethyol, Merrem, & Zomig. Primary responsibilities include: + Preparation of the annual, quarterly and long range budgeting process + Manage marketing expense budget and provide commentary on variances + Complete the monthly accounting close process + Financial accounting for all authorized generics and outsourced Brands within Cornerstone + Provide financial support and analysis to business partners Special Project: + Led the integration of oncology portfolios between recently acquired MedImmune into AZ for US marketplace

  • Financial Analyst

    2003 - 2007

    Supported the Sales & Marketing skill centers through prudent financial discipline of headcount and expenses. Responsibilities: + Cost center management of headcount and expenses + Financially support Field Force allocation model across promoted product portfolio + Compensation and fringe benefit calculations including separation and relocation expenses + Field Sales cost modeling to support Business Development + Provide financial support and analysis to business partners Special Project: + Financial modeling to support reorganizations of the Marketing Organization and the Field Sales force

2001 - 2002

  • Finance Summer Intern

    2001 - 2002

    Summer Intern (2 consecutive summers) in Central Planning & Reporting. Supported mid-year budget refresh through building and consolidating excel based templates for US Marketing Company.